Related Experiment Video
Updated: Aug 5, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Navigating the Debate on Menopausal Hormonal Therapy and Practical Prescribing
Genevieve Hofmann1, Nanette Santoro1
1University of Colorado Anschutz School of Medicine, Aurora, CO, USA.
Abstract:
The menopause transition can be a time of significant symptoms that impact quality of life and long-term health. Symptoms often go untreated due to lack of clinician knowledge about the safety of menopause hormone therapy (MHT) or comfort and facility with its prescribing. Experts agree that MHT is safe and effective for most people. The timing, route, and dose of therapy are important considerations for practical and safe prescribing.
Related Concept Videos
Menopause
Hormonal Regulation
Hormonal Regulation
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Therapeutic Drug Monitoring: Affecting Factors
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
